IL-17A Inhibitors Appear Effective in Treating AS, But Safety Needs Further Study
News
Medications that block the activity of the pro-inflammatory molecule interleukin-17A (IL-17A) can ease symptoms of ankylosing spondylitis (AS), but further research is needed to evaluate their safety, according to an ... Read more